Revenue | ₹314.03Cr |
Net Profits | ₹-10.10Cr |
Net Profit Margins | -3.22% |
Solara Active Pharma Sciences Ltd’s revenue fell -9.57% since last year same period to ₹314.03Cr in the Q2 2025-2026. On a quarterly growth basis, Solara Active Pharma Sciences Ltd has generated -1.91% fall in its revenue since last 3-months.
Solara Active Pharma Sciences Ltd’s net profit fell -226.09% since last year same period to ₹-10.10Cr in the Q2 2025-2026. On a quarterly growth basis, Solara Active Pharma Sciences Ltd has generated -196.01% fall in its net profits since last 3-months.
Solara Active Pharma Sciences Ltd’s net profit margin fell -239.44% since last year same period to -3.22% in the Q2 2025-2026. On a quarterly growth basis, Solara Active Pharma Sciences Ltd has generated -197.87% fall in its net profit margins since last 3-months.
The revenue for Solara Active Pharma Sciences Ltd in the Q2 results 2025 was ₹314.03Cr.
The net profit for Solara Active Pharma Sciences Ltd in the Q2 results 2025 was ₹-10.10Cr.
The net profit margin for Solara Active Pharma Sciences Ltd in the Q2 results 2025 was -3.22%.
The revenue for Solara Active Pharma Sciences Ltd in the Q2 results 2024 was ₹347.27Cr.
The net profit for Solara Active Pharma Sciences Ltd in the Q2 results 2024 was ₹8.01Cr.
The net profit margin for Solara Active Pharma Sciences Ltd in the Q2 results 2024 was 2.31%.